For people with kidney failure, home dialysis can offer more freedom and better quality of life. So what’s stopping the NHS ...

A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

While immunosuppressive medications are critical to preventing rejection of transplant organs, they also come with plenty of ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status ...

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...

Ten weeks after a New England man received a kidney transplant, he went into respiratory failure and shock — thanks to an extensive parasitic worm infection, according to his medical team. The ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with AMI.

The hepatitis E virus (HEV) causes severe liver inflammation. A research team from Ruhr University Bochum, Germany, and TWINCORE, the Center for Experimental and Clinical Infection Research in ...